Warrant No. MA-[ ] Dated: March 2, 2007Iomai Corp • March 2nd, 2007 • Pharmaceutical preparations
Company FiledMarch 2nd, 2007 IndustryIOMAI CORPORATION, a Delaware corporation (the “Company”), hereby certifies that, for value received, or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of shares of common stock, $0.01 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $5.25 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time on or after the date hereof (the “Initial Exercise Date”) and through and including the date that is five years from the date of issuance hereof (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are
Warrant No. MB-[ ] Dated: March 2, 2007Iomai Corp • March 2nd, 2007 • Pharmaceutical preparations
Company FiledMarch 2nd, 2007 IndustryIOMAI CORPORATION, a Delaware corporation (the “Company”), hereby certifies that, for value received, ___ or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of ___ shares of common stock, $0.01 par value per share (the "Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the "Warrant Shares”) at an exercise price equal to $5.25 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time on or after the date hereof (the "Initial Exercise Date”) and through and including the date that is four (4) months after the Effective Date (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrant